PHGDH and melanoma: Phosphoglycerate dehydrogenase (PHGDH), the first enzyme, which diverts glucose-derived carbon into de novo serine synthesis pathway, was found to be amplified and overexpressed in melanoma, indicating its clinically relevant potential.